SuspendedPhase 1

Exercise and Prevention of Syncope: EXPOSE

Stopped: No Resources - No Personnel

Canada20 participantsStarted 2006-03

Plain-language summary

The purpose of this study is to determine whether eight weeks of exercise performed at an intensity of approximately 65% VO2max will improve symptoms associated with fainting (vasovagal syncope).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: a diagnosis of vasovagal syncope as the cause of loss of consciousness, \>1 lifetime syncope spell preceding enrolment, \>-3 points on the S3 score for structurally normal hearts, \>18 yrs of age with informed consent - Exclusion Criteria: subjects with a negative Physical Activity Readiness Questionnaire (PARQ), those who are unable to provide informed consent, those with a VO2max \>55ml/kg/min, those who exercise more than 30 minutes per day, 3 times per week, other causes of syncope, individuals with valvular, coronary, myocardial, or conductive abnormality, significant arrhythmia, hypertrophic cardiomyopathy, permanent pacemaker, seizure disorder, heart failure, major chronic cardiovascular disease, or renal dysfunction. \-

What they're measuring

Orthostatic tolerance - this will be measured at baseline and post intervention

Trial details

NCT IDNCT00203593

SponsorUniversity of Calgary

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Syncope trials